Blog Particle 1
Blog Particle 2

News & updates from Zinc HQ

Respiro Diagnostics raises £1m to transform lung cancer detection
3 MINS READ
Respiro Diagnostics raises £1m to transform lung cancer detection
July 8, 2026 By Kate Hyslop
10 MINS READ

Investing in Neurolase to bring precision, AI and real-time molecular insight into brain surgery

June 23, 2026 By Kate Hyslop
8 MINS READ

Meet Anocis: Building a new generation of safer pain and itch treatments

June 15, 2026 By Kate Hyslop
6 MINS READ

Announcing Zinc’s investment in KiloGen: Building the future of molecular glue drug discovery

June 15, 2026 By Kate Hyslop
6 MINS READ

Trapping brain cancer: Why Zinc is backing Migration BioTherapeutics

April 28, 2026 By Kate Hyslop
6 MINS READ

Tackling heart disease at its roots: Why Zinc invested in SignaCor

March 30, 2026 By Natalie Pankova, PhD
7 MINS READ

Introducing IonSight: The measurement engine behind the future of drug discovery

March 9, 2026 By Kate Hyslop
7 MINS READ

Zinc backs BioHarv: the future of battery-free, heart-powered medical devices

February 3, 2026 By Emilie Syed
5 MINS READ

Zinc Backs Anemo Labs to Build the Future of Medical Olfaction

November 24, 2025 By Kate Hyslop
8 MINS READ

Introducing Zinc’s 2025 Science-for-Impact Report

October 14, 2025 By Kate Hyslop
7 MINS READ

Spotlight on Joey: Building the Future of Children’s Healthcare

September 9, 2025 By Kate Hyslop
5 MINS READ

Investing in Isoform Oncology: On a mission to treat the untreatable

June 19, 2025 By Emilie Syed, Senior Investment Manager, Zinc
4 MINS READ

Introducing Serenatis Bio: Transforming the OCD therapeutics landscape

June 3, 2025 By Natalie Pankova, MD Deeptech & Healthcare, Zinc